PD-L2 expression in colorectal cancer: Independent prognostic effect and targetability by deglycosylation

Colorectal cancer (CRC) is the second leading cause of cancer death worldwide, and immune checkpoint blockade therapy provides an opportunity for improving the outcome of CRC patients. Recent studies suggest that programmed death ligand-1 (PD-L1) is only expressed in 12% of CRCs. Here, we demonstrat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Wang, Huanbin, Yao, Han, Li, Chushu, Liang, Lunxi, Zhang, Yao, Shi, Hubing, Zhou, Chongzhi, Chen, Yingxuan, Fang, Jing-Yuan, Xu, Jie
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5543903/
https://ncbi.nlm.nih.gov/pubmed/28811964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1327494
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars